Stay updated on Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.

Latest updates to the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe page has been updated to reflect an increase in the number of study locations from 54 to 60, and it includes new clinical research sites in Chile and Argentina. Additionally, there is a note about the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025.SummaryDifference5%
- Check43 days agoChange DetectedThe study has expanded to include 54 locations, with new sites added in Los Angeles, San Francisco, Fort Myers, Tampa, Fairfax, Richmond, Vancouver, and Turkey, while some previous locations have been removed.SummaryDifference8%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study criteria and descriptions related to the drug Seladelpar for Primary Biliary Cholangitis, while a new identifier and revision number have been added.SummaryDifference18%
Stay in the know with updates to Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.